my A1c moved and I cannot work out whether phase 2 is why
Long-ish post, sorry. tl;dr at the bottom. I have been tracking retatrutide against eGFR for 31 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one lab, one…
This is correct. Triple agonism is genuinely different.
The glucagon component does different things than dual agonism. The nausea are not just amplified versions.
the dosing is steep, the sulphur burps reports are real, and nobody knows the human safety yet
the 7.5mg arm is different from 5mg, results do not transfer
the weight curves are unusually steep, which makes predicting individual response harder
nobody should be giving this to anyone without extensive monitoring
phase 2 numbers are not maintenance numbers, cite the trial
triple agonism is glucagon, do not generalise